LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 22.10
+0.30 (1.38%)
Apr 20, 2026, 1:24 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 723.74 million as of April 20, 2026. Its market cap has increased by 31.87% in one year.
Market Cap
723.74M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22.10
Market Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has increased from 721.03M to 723.74M, an increase of 0.38%. That is a compound annual growth rate of 0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 707.51M | -6.84% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 1.12B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.03B |
| TCI GENE | 967.06M |
| Taiwan Advance Bio-Pharmaceutical | 945.00M |
| NatureWise Biotech & Medicals | 914.20M |
| BioLASCO Taiwan | 778.60M |
| Neith | 749.77M |